~ OCLG = Oncologix Announces Third~Quarter~Results
Post# of 178
Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating divisions in Advanced Medical Products, Healthcare Services and Durable Medical product sales and distribution, announced its financial results for the three and nine months ending May 31, 2015 and May 31, 2014.
Financial Highlights over the past nine months
View data
-- Revenues for the three and nine months ending May 31, 2015 were $1,235,656 and $3,625,407, respectively, up from $988,385 and $2,696,776, an increase of 25% and 34%, respectively, from the comparable periods in 2014. -- Gross margins for the three and nine months ending May 31, 2015 were $350,060 and $996,610, respectively, up from $199,628 and $629,976, an improvement of 75% and 58%, respectively, from the comparable periods in 2014. -- General and administrative expenses for the nine months ended May 31, 2015 were $1,379,769, up from $999,910 in fiscal 2014, an increase due to additional general and administrative expenses from the acquisition of Esteemcare. -- During the past nine months, the Company has repaid over $1,470,000 of corporate debt. During the nine months ended May 31, 2015, OCLG raised $1,056,968 through various financing activities, up from $664,818, for the comparable period in 2014.